Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA
2020-09-25 10:37
GenScript ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program
2020-09-24 22:00
Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases
2020-09-24 08:00
ImmVira Announces US$10 million Strategic Series B Plus Financing with SIIC Capital
2020-09-24 00:09
Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau
2020-09-23 15:00
Alcohol Detection Anklets Showing Promise in NZ
2020-09-22 04:24
China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks
2020-09-21 20:30
I-Mab Announces China NMPA Clearance for Phase 1 Clinical Trial of Lemzoparlimab in Relapsed or Refractory Advanced Lymphoma
2020-09-21 20:00
PharmAbcine expands partnership with Samsung Biologics for PMC-403
2020-09-21 20:00
WellsCare signs in-store contract with b8ta for IASO
2020-09-20 20:00
Preparation products of Yiling Pharma approved by FDA for launch in the US market
2020-09-19 19:14
MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer
2020-09-18 04:05
Dr. Steven Yu Joins ChemPartner as Vice President of Regulated Bioanalysis
2020-09-17 23:01
Expanding Their Existing Strategic Collaboration, GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc.
2020-09-17 22:00
Samsung Biologics signs development agreement with Panolos for solid tumor treatment
2020-09-17 08:43
Transcenta Successfully Scaled up the Continuous Perfusion Process and Completed GMP Manufacturing of a Novel Bispecific Antibody for Cancer Immunotherapy
2020-09-15 23:00
Verkada Introduces Environmental Sensor to Provide Enhanced Visibility into Physical Spaces
2020-09-15 21:40
PharmAbcine Unveils Olinvacimab's Positive Results from Phase Ib Combination Studies at KSMO 2020
2020-09-14 20:00
Coronavirus Breakthrough: Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient - Discharged Following Five Days of Treatment
2020-09-12 08:34
NaviFUS Launches Neuronavigation-guided Clinical Trial to Open the Blood-Brain-Barrier for Combination FUS-Bevacizumab Therapy in rGBM Patients
2020-09-11 20:55
1
200
201
202
203
204
439